AAAAAA

   
Results: 1-9 |
Results: 9
Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol
Authors: Tan, HP Markowitz, JS Montgomery, RA Merritt, WT Klein, AS Thuluvath, PJ Poordad, FF Maley, WR Winters, B Akinci, SB Gaine, SP
Citation: Hp. Tan et al., Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol, LIVER TRANS, 7(8), 2001, pp. 745-749
Increased levels of prostaglandin D-2 suggest macrophage activation in patients with primary pulmonary hypertension
Authors: Robbins, IM Barst, RJ Rubin, LJ Gaine, SP Price, PV Morrow, JD Christman, BW
Citation: Im. Robbins et al., Increased levels of prostaglandin D-2 suggest macrophage activation in patients with primary pulmonary hypertension, CHEST, 120(5), 2001, pp. 1639-1644
Primary pulmonary hypertension is not associated with scleroderma-like changes in nailfold capillaries
Authors: Greidinger, EL Gaine, SP Wise, RA Boling, C Housten-Harris, T Wigley, FM
Citation: El. Greidinger et al., Primary pulmonary hypertension is not associated with scleroderma-like changes in nailfold capillaries, CHEST, 120(3), 2001, pp. 796-800
Recreational use of Aminorex and pulmonary hypertension
Authors: Gaine, SP Rubin, LJ Kmetzo, JJ Palevsky, HI Traill, TA
Citation: Sp. Gaine et al., Recreational use of Aminorex and pulmonary hypertension, CHEST, 118(5), 2000, pp. 1496-1500
Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus
Authors: Robbins, IM Gaine, SP Schilz, R Tapson, VF Rubin, LJ Loyd, JE
Citation: Im. Robbins et al., Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus, CHEST, 117(1), 2000, pp. 14-18
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - A randomized, controlled trial
Authors: Badesch, DB Tapson, VF McGoon, MD Brundage, BH Rubin, LJ Wigley, FM Rich, S Barst, RJ Barrett, PS Kral, KM Jobsis, MM Loyd, JE Murali, S Frost, A Girgis, R Bourge, RC Ralph, DD Elliott, CG Hill, NS Langleben, D Schilz, RJ McLaughlin, VV Robbins, IM Groves, BM Shapiro, S Medsger, TA Gaine, SP Horn, E Decker, JC Knobil, K
Citation: Db. Badesch et al., Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - A randomized, controlled trial, ANN INT MED, 132(6), 2000, pp. 425
Primary pulmonary hypertension (vol 352, pg 719, 1998)
Authors: Gaine, SP Rubin, LJ
Citation: Sp. Gaine et Lj. Rubin, Primary pulmonary hypertension (vol 352, pg 719, 1998), LANCET, 353(9146), 1999, pp. 74-74
Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher's disease
Authors: Bakst, AE Gaine, SP Rubin, LJ
Citation: Ae. Bakst et al., Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher's disease, CHEST, 116(4), 1999, pp. 1127
Anastomotic pulmonary hypertension after lung transplantation for primary pulmonary hypertension - Report of surgical correction
Authors: Soriano, CM Gaine, SP Conte, JV Fairman, RP White, C Rubin, LJ
Citation: Cm. Soriano et al., Anastomotic pulmonary hypertension after lung transplantation for primary pulmonary hypertension - Report of surgical correction, CHEST, 116(2), 1999, pp. 564-566
Risultati: 1-9 |